Blog - Page 4168 of 5482

MondayNov 03, 2008 4:44 am

Pacific Ridge Exploration Ltd. (TSX: PEX CN)

Pacific Ridge Exploration Ltd. (TSX: PEX CN) is primarily focused on discovering and developing for phosphate in British Columbia. The company recently acquired two phosphate projects in the interior of British Columbia, each offering the opportunity of a multi-deposit discovery. The Baker Basin Project, flagship project of Pacific Ridge, is located in an emerging uranium district in south-western Nunavut. Baker is over 190,000 hectares in size and is known to host at least 20 uranium prospects. For further information, visit the Company's web site at www.pacificridgeexploration.com.

MondayNov 03, 2008 4:44 am

BNK Petroleum Inc. (TSX: BKX CN)

BNK Petroleum Inc. (TSX: BKX CN), a California-based energy company, is focused on acquiring, exploring, and producing large oil and gas reserves. The company operates in the United States through its wholly-owned subsidiary BNK Petroleum (US) Inc., with properties located in Oklahoma, Texas, New York, Mississippi and Alabama. BNK Petroleum aggressively targets growth in production and reserves by tactically leveraging new and proven technologies. For further information, visit the Company's web site at www.bnkpetroleum.com.

MondayNov 03, 2008 4:43 am

Oxygen Biotherapeutics, Inc. (OTC BB: OXBO)

Oxygen Biotherapeutics, Inc. (OTC BB: OXBO), previously known as Synthetic Blood International, Inc., is focused on transforming patient care through the development of advanced oxygen-based therapies using Oxycyte®, the company’s perfluorocarbon (PFC) therapeutic oxygen carrier, and other solutions. Oxycyte could potentially be used in numerous indications, including traumatic brain injury, sickle-cell pain crisis, decompression sickness, stroke, heart attack, and wound treatment. For further information, visit the Company's web site at www.oxybiomed.com.

MondayNov 03, 2008 4:43 am

Blue Note Mining (TSX: BN)

Blue Note Mining (TSX: BN CN) was founded with the purpose of taking advantage of Canadian metals mining opportunities. The company’s first asset acquisition was the Caribou and Restigouche lead-zinc mines located near Bathurst, New Brunswick. Blue Note intends to make other corporate and asset acquisitions in the near term future. Their exploration strategy is focused on providing a continuous source of sulphide ore feed for the concentrator at the Caribou mine/mill complex. For further information, visit the Company's web site at www.bluenotemining.ca.

MondayNov 03, 2008 4:43 am

OXiGENE, Inc. (NASDAQ: OXGN)

OXiGENE, Inc. (NASDAQ: OXGN), a biopharmaceutical company, is focused on finding and developing new and improved therapeutics that attend to the substantial, but unmet needs of patients diagnosed with cancer and eye disease. The company’s primary focus is on the development and commercialization of first-in-class and best-in-class vascular disrupting agents (VDAs) designed to treat cancer and eye disease. To date, OXiGENE's VDA product candidates have shown considerable potential in human clinical studies. For further information, visit the Company's web site at www.oxigene.com.

MondayNov 03, 2008 4:42 am

Osteologix, Inc. (OTC BB: OLGX)

Osteologix, Inc. (OTC BB: OLGX), a specialty biopharmaceutical company, has dedicated their efforts to improving the health of those afflicted with musculoskeletal diseases through the development of innovative therapies. NB S101, the company’s lead investigational product candidate, is an innovative pharmaceutical agent designed to treat and prevent osteoporosis. Their mission is to partner with the healthcare community to apply new scientific information to the development of beneficial products. For more information please visit www.osteologix.com.

MondayNov 03, 2008 4:42 am

BioSphere Medical, Inc. (NASDAQ: BSMD)

BioSphere Medical, Inc. (NASDAQ: BSMD) is focused on applying their proprietary microsphere technology to medical applications through the use of embolotherapy techniques. The company’s core technologies consist of patented bio-engineered polymers and manufacturing methods, which are used to produce miniature spherical beads with uniquely beneficial properties for a variety of medical applications. For further information, visit the Company's web site at www.equityny.com.

MondayNov 03, 2008 4:42 am

Osiris Therapeutics, Inc. (NASDAQ: OSIR)

Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading stem cell therapeutic company, has their focus on developing and marketing products for the treatment of medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The company’s stem cell products have major therapeutic potential because of their ability to promote tissue regeneration, regulate inflammation and prevent pathological scar formation. For further information, visit the Company's web site at www.osiris.com.

MondayNov 03, 2008 4:41 am

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI)

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI), a commercial-stage pharmaceutical company, is devoted to marketing two FDA-approved products in the United States: ANTARA® capsules, a cardiovascular product; and FACTIVE® tablets, a fluoroquinolone antibiotic. ANTARA is designed to treat hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with diet. FACTIVE is designed to treat acute bacterial exacerbations of chronic bronchitis and pneumonia. For further information, visit the Company's web site at www.oscient.com.

MondayNov 03, 2008 4:41 am

BioSpecifics Technologies Corp. (OTC BB: BSTC)

BioSpecifics Technologies Corp. (OTC BB: BSTC), a biopharmaceutical company, has developed and licensed injectable collagenase for three clinical indications. Their development and licensing agreement with Auxilium Pharmaceuticals (Nasdaq GM: AUXL) is for clinical indications in Dupuytren’s disease, Peyronie’s disease and frozen shoulder (adhesive capsulitis). Currently, all of their efforts are focused on the future development and commercialization of injectable collagenase products. For further information, visit the Company's web site at www.biospecifics.com.

Site Search

Company Search

Pacific Ridge Exploration Ltd. (TSX: PEX CN)

BNK Petroleum Inc. (TSX: BKX CN)

Oxygen Biotherapeutics, Inc. (OTC BB: OXBO)

Blue Note Mining (TSX: BN)

OXiGENE, Inc. (NASDAQ: OXGN)

Osteologix, Inc. (OTC BB: OLGX)

BioSphere Medical, Inc. (NASDAQ: BSMD)

Osiris Therapeutics, Inc. (NASDAQ: OSIR)

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI)

BioSpecifics Technologies Corp. (OTC BB: BSTC)

Market Basics

Newsletter Publishers

Public Companies